Pancreatic Cancer Research

ResearcherRoyal Marsden NHS Foundation TrustActive in the last 2 years

Uwe Oelfke

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2309-0814; OpenAlex author ID A5076107114. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. A robust auto-contouring and data augmentation pipeline for adaptive MRI-guided radiotherapy of pancreatic cancer with a limited dataset. Last author DOI 10.1088/1361-6560/adabac↗
  2. Comparison of the dose escalation potential for two hypofractionated radiotherapy regimens for locally advanced pancreatic cancer. Co-author DOI 10.1016/j.ctro.2019.03.001↗
  3. Worst case optimization for interfractional motion mitigation in carbon ion therapy of pancreatic cancer. Co-author DOI 10.1186/s13014-016-0705-8↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mehdi Shojaei · 1 shared paper, 2025 · strength 0.27
  2. Katharine L. Aitken · 1 shared paper, 2019 · strength 0.10
  3. Jenny Bertholet · 1 shared paper, 2019 · strength 0.10
  4. Mark Bangert · 1 shared paper, 2016 · strength 0.07
  5. Julian Steitz · 1 shared paper, 2016 · strength 0.07
  6. Patrick Naumann · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.